{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:27:57Z","timestamp":1789194477655,"version":"build-2803163510"},"reference-count":51,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2024,4,8]]},"published-print":{"date-parts":[[2024,7]]},"DOI":"10.2967\/jnumed.123.267208","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T18:25:14Z","timestamp":1715279114000},"page":"1064-1069","source":"Crossref","is-referenced-by-count":11,"title":["Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection"],"prefix":"10.2967","volume":"65","author":[{"given":"Surekha","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Kurkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Saelee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Morley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Lawhn-Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"2024070106251398000_65.7.1064.1","doi-asserted-by":"crossref","first-page":"20160915","DOI":"10.1259\/bjr.20160915","article-title":"In vivo dosimetry in UK external beam radiotherapy: current and future usage","volume":"90","author":"MacDougall","year":"2017","journal-title":"Br J Radiol."},{"key":"2024070106251398000_65.7.1064.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.07.1754"},{"key":"2024070106251398000_65.7.1064.3","doi-asserted-by":"publisher","DOI":"10.1118\/1.4811216"},{"key":"2024070106251398000_65.7.1064.4","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1200\/JCO.20.01024","article-title":"Hypofractionated versus conventional fractionated radiotherapy after breast-conserving surgery in the modern treatment era: a multicenter, randomized controlled trial from China","volume":"38","author":"Wang","year":"2020","journal-title":"J Clin Oncol."},{"key":"2024070106251398000_65.7.1064.5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0360-3016(91)90180-C","article-title":"Three-dimensional treatment planning for lung cancer","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2024070106251398000_65.7.1064.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01363"},{"key":"2024070106251398000_65.7.1064.7","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1470-2045(19)30410-3","article-title":"Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial","volume":"20","author":"Nichols","year":"2019","journal-title":"Lancet Oncol."},{"key":"2024070106251398000_65.7.1064.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.026"},{"key":"2024070106251398000_65.7.1064.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32487-5"},{"key":"2024070106251398000_65.7.1064.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-843540"},{"key":"2024070106251398000_65.7.1064.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262751"},{"key":"2024070106251398000_65.7.1064.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262750"},{"key":"2024070106251398000_65.7.1064.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2824-5"},{"key":"2024070106251398000_65.7.1064.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.148437"},{"key":"2024070106251398000_65.7.1064.15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1159\/000504001","article-title":"177Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors","volume":"110","author":"Jahn","year":"2020","journal-title":"Neuroendocrinology."},{"key":"2024070106251398000_65.7.1064.16","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00259-023-06257-6","article-title":"The relationship between tumour dosimetry, response, and overall survival in patients with unresectable neuroendocrine neoplasms (NEN) treated with 177Lu DOTATATE (LuTate)","volume":"50","author":"Alipour","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024070106251398000_65.7.1064.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00237-3"},{"key":"2024070106251398000_65.7.1064.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2024070106251398000_65.7.1064.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.219352"},{"key":"2024070106251398000_65.7.1064.20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/diagnostics11030428","article-title":"Correlation of an index-lesion-based SPECT dosimetry method with mean tumor dose and clinical outcome after 177Lu-PSMA-617 radioligand therapy","volume":"11","author":"V\u00f6lter","year":"2021","journal-title":"Diagnostics (Basel)."},{"key":"2024070106251398000_65.7.1064.21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00259-018-4209-7","article-title":"Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial","volume":"46","author":"Del Prete","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024070106251398000_65.7.1064.22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40658-023-00561-8","article-title":"Tumor dosimetry using 177Lu: influence of background activity, measurement method and reconstruction algorithm","volume":"10","author":"Staanum","year":"2023","journal-title":"EJNMMI Phys."},{"key":"2024070106251398000_65.7.1064.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.100123"},{"key":"2024070106251398000_65.7.1064.24","first-page":"44","article-title":"Partial volume effect in SPECT & PET imaging and impact on radionuclide dosimetry estimates","volume":"11","author":"Marquis","year":"2023","journal-title":"Asia Ocean J Nucl Med Biol."},{"key":"2024070106251398000_65.7.1064.25","unstructured":"Nelson AS Horstman BP . Quantitative SPECT\/CT reconstruction with SPECTRA Quant\u00ae. MIM Software website. https:\/\/www.mimsoftware.com\/portal\/login?originalUrl=%2Fportal%2Ftraining%2Fradiology_nuc_med%2Fwhite_papers. Published February 7, 2022. Accessed October 23, 2023."},{"key":"2024070106251398000_65.7.1064.26","unstructured":"Cole NM Mirando D Nelson AS . Make it easy with single timepoint dosimetry. MIM Software website. https:\/\/go.mimsoftware.com\/single-timepoint-dosimetry-white-paper. Published June 20, 2022. Accessed October 23, 2023."},{"key":"2024070106251398000_65.7.1064.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.193706"},{"key":"2024070106251398000_65.7.1064.28","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/mp.12880","article-title":"Experimental validation of absolute SPECT\/CT quantification for response monitoring in breast cancer","volume":"45","author":"Collarino","year":"2018","journal-title":"Med Phys."},{"key":"2024070106251398000_65.7.1064.29","doi-asserted-by":"publisher","DOI":"10.1016\/S1095-0397(99)00016-3"},{"key":"2024070106251398000_65.7.1064.30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2702"},{"key":"2024070106251398000_65.7.1064.31","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.240242"},{"key":"2024070106251398000_65.7.1064.32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1148\/radiol.2016142043","article-title":"Lodge MA, Wahl RL. Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0","volume":"280","author":"O JH","year":"2016","journal-title":"Radiology."},{"key":"2024070106251398000_65.7.1064.33","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263072"},{"key":"2024070106251398000_65.7.1064.34","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.233411"},{"key":"2024070106251398000_65.7.1064.35","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264594"},{"key":"2024070106251398000_65.7.1064.36","doi-asserted-by":"crossref","unstructured":"Peterson AB Mirando DM Dewaraja YK . Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in clinical patients and realistic simulations. PubMed website. https:\/\/pubmed.ncbi.nlm.nih.gov\/37131738\/. Published April 21, 2023. Accessed April 23, 2024.","DOI":"10.21203\/rs.3.rs-2829731\/v1"},{"key":"2024070106251398000_65.7.1064.37","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.254656"},{"key":"2024070106251398000_65.7.1064.38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00259-021-05471-4","article-title":"Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome","volume":"49","author":"Peters","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024070106251398000_65.7.1064.39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12032-021-01503-z","article-title":"The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors","volume":"38","author":"Une","year":"2021","journal-title":"Med Oncol."},{"key":"2024070106251398000_65.7.1064.40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2991"},{"key":"2024070106251398000_65.7.1064.41","first-page":"1775","article-title":"Tumor hypoxia detected by 18F-fluoromisonidazole positron emission tomography (FMISO PET) as a prognostic indicator of radiotherapy (RT)","volume":"38","author":"Tachibana","year":"2018","journal-title":"Anticancer Res."},{"key":"2024070106251398000_65.7.1064.42","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(21)00347-8","article-title":"Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis","volume":"22","author":"Scott","year":"2021","journal-title":"Lancet Oncol."},{"key":"2024070106251398000_65.7.1064.43","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30648-9"},{"key":"2024070106251398000_65.7.1064.44","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-0859"},{"key":"2024070106251398000_65.7.1064.45","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2806"},{"key":"2024070106251398000_65.7.1064.46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.euf.2016.09.005","article-title":"Interrogating metastatic prostate cancer treatment switch decisions: a multi-institutional survey","volume":"4","author":"Lorente","year":"2018","journal-title":"Eur Urol Focus."},{"key":"2024070106251398000_65.7.1064.47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/cpf.12480","article-title":"68Ga\u2010PSMA PET\/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature","volume":"38","author":"Zacho","year":"2017","journal-title":"Clin Physiol Funct Imaging."},{"key":"2024070106251398000_65.7.1064.48","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s13139-018-0548-3","article-title":"Evaluation of RECIST, PERCIST, EORTC, and MDA criteria for assessing treatment response with Ga68-PSMA PET-CT in metastatic prostate cancer patient with biochemical progression: a comparative study","volume":"52","author":"Gupta","year":"2018","journal-title":"Nucl Med Mol Imaging."},{"key":"2024070106251398000_65.7.1064.49","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.233817"},{"key":"2024070106251398000_65.7.1064.50","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.260836"},{"key":"2024070106251398000_65.7.1064.51","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264677"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.123.267208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T13:26:40Z","timestamp":1719840400000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.123.267208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,1]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.2967\/jnumed.123.267208"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.123.267208","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}